Washington Report Articles
The U.S. Department of Health and Human Services has a new program to help care for mental and behavioral illnesses.
The Department of Health and Human Services and the Department of Veterans Affairs have developed a demonstration of the standards to permit sensitive health information to be shared responsibly among providers using electronic health records, while abiding by confidentiality rules and guidelines.
The U.S. House of Representatives Energy and Commerce Committee has approved H.R. 1206, the Access to Professional Health Insurance Advisors Act, with a 26-14 vote.
Beginning in 2014, nearly six million U.S. citizens are expected to purchase health insurance or face an average tax penalty of $1,200, following a Supreme Court 5-4 decision this past summer that upheld the constitutionality of the Affordable Care Act.
The U.S. House of Representatives has introduced a bill that intends to clarify and shorten the U.S. Food and Drug Administration’s assessment process of mobile health apps.
The U.S. Department of Health and Human Services established three new centers to produce vaccines and other medications used to safeguard public health in the face of crises.
On July 9, 2012, President Obama signed into law the Food and Drug Administration Safety and Innovation Act, also known as S. 3187.
The Centers for Medicare and Medicaid Services issued new rules on May 10, 2012, to reduce redundant and outdated regulations on American hospitals and healthcare providers in order to decrease costs and allow for more emphasis on medical care.
Department of U.S. Health and Human Services (HHS) Secretary Kathleen Sebelius released an aggressive plan to combat Alzheimer’s disease at the Alzheimer’s Research Summit held May 15.
Increased coverage for young people may be due to a provision in the Affordable Care Act that allows children to stay on their parents’ insurance policies until their 26th birthday.
In May 2012, the Obama Administration committed $728 million to renovate and grow 398 community health centers.
On March 26 2012, the U.S. Supreme Court instructed the Federal Circuit Court of Appeals to reconsider its July 2011 decision to uphold patents held by Myriad Genetics.